Product Description
Overall, the global peripheral thrombus management market was valued at $1.3 billion in 2025. This is expected to increase over the forecast period at a CAGR of 7.3% to reach $2.2 billion.
The full report suite on the global market for peripheral thrombus management covers seven geographical regions: North America, Latin America, Western Europe, Central and Eastern Europe, the Middle East, Asia-Pacific and Africa. For each region, the report provides market valuation, unit analysis and ASP.
This report is part of a larger suite that covers the global market for complex peripheral vascular (PV) devices including PV stents, percutaneous transluminal angioplasty (PTA) balloon catheters, drug-coated balloons (DCBs), atherectomy devices, intravascular lithotripsy (IVL) systems, chronic total occlusion (CTO) devices, surgical grafts, stent grafts, embolic protection devices (EPDs), peripheral thrombus management and peripheral intravascular ultrasound (IVUS) catheters.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Peripheral Thrombus Management Market Trends
Thrombectomy procedures are much higher priced than drug treatments, balloon angioplasty and stenting. In fact, physicians are using simple guide catheters and long sheaths to access the lesion to manually aspirate the thrombus. In order to minimize costs, hospitals will use these alternative procedures when possible.
Global Peripheral Thrombus Management Market Share Insights
- Inari Medical swiftly gained significant market share through its ClotTriever® and FlowTriever® devices, both capable of use without thrombolytics, resulting in significantly reduced treatment times for patients. FlowTriever®, approved in 2018, is the second approved device specifically designed for PE treatment and has garnered a substantial share of the market due to its premium pricing compared with EkoSonic®. ClotTriever®, indicated for use in the peripheral vasculature, including deep vein thrombosis (DVT) treatment, caters to another rapidly growing market. Inari Medical is well positioned to further expand and increase its market share.
- Penumbra focused solely on the traditional thrombectomy market segment, offering the INDIGO® CAT®, Separator® and Pump MAX™ product families. These products are primarily used in arterial and venous applications. The INDIGO® CAT® and Separator catheters work together with the Pump MAX™ console, although the console is not covered in this analysis.
- BTG held the leading position in the total U.S. peripheral thrombus management market prior to its acquisition by Boston Scientific in August 2019. Following the acquisition, Boston Scientific became the third-leading competitor in the total market in 2024. Historically, BTG secured its leadership through a dominant presence in the pharmacomechanical thrombectomy (PMT) segment, where it captured nearly two-thirds of the market with its EkoSonic® system. With ownership of the only two products in the PMT category, Boston Scientific has maintained a strong share, competing in two of the fastest-growing thrombectomy segments: deep vein thrombosis (DVT) and pulmonary embolism (PE). The AngioJet® Peripheral Thrombectomy System represents the remaining share of the PMT market.
Global Peripheral Thrombus Management Market Segmentation Summary
- Peripheral Thrombus Management Market – Further Segmented Into:
- Device Type: Traditional Thrombectomy Device, Pharmacomechanical Thrombectomy Device, and Catheter Directed Thrombolysis.
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
